{"disease":{"id":"thrombosis-embolism","name":"thrombosis embolism"},"drugs":{"marketed":[{"drug_id":"heparin","indication_name":"Deep Vein Thrombosis with Pulmonary Embolism","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Heparin Sodium In Plastic Container","generic_name":"HEPARIN","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Antithrombin-III","drug_class":"Anti-coagulant","quality_score":56,"revenue":null,"mechanism":"Heparin works by binding to Antithrombin-III, a protein that inhibits the formation of blood clots."},{"drug_id":"heparin-sodium","indication_name":"Deep Vein Thrombosis with Pulmonary Embolism","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Heparin Sodium In Plastic Container","generic_name":"Heparin Sodium","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"Antithrombin III, Coagulation Factors Xa and IIa","drug_class":"Anticoagulant","quality_score":63,"revenue":null,"mechanism":"Heparin enhances Antithrombin III activity to inhibit coagulation factors Xa and IIa."},{"drug_id":"warfarin","indication_name":"Deep Vein Thrombosis with Pulmonary Embolism","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Coumadin","generic_name":"warfarin","company_name":"Generic (originally Wisconsin Alumni Research Foundation)","drug_phase":"marketed","molecular_target":"Vitamin K epoxide reductase complex subunit 1-like protein 1, Cytochrome P450 2C9, Proprotein convertase subtilisin/kexin type 7","drug_class":"Vitamin K antagonist (anticoagulant)","quality_score":60,"revenue":null,"mechanism":"Inhibits vitamin K epoxide reductase, blocking the synthesis of vitamin K-dependent clotting factors (II, VII, IX, X) to prevent thrombosis."}],"pipeline":[],"offLabel":[],"totalMarketed":3,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01947959","title":"Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany)","phase":"","overall_status":"COMPLETED","enrollment_count":665533,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT03271450","title":"The DARE Warfarin CER Study","phase":"","overall_status":"UNKNOWN","enrollment_count":416000,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT04838106","title":"Outcomes of Patients Who Survived Treatment on an Intensive Care Unit for COVID-19 in England and Wales","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":319600,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT03835780","title":"The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study","phase":"","overall_status":"COMPLETED","enrollment_count":266890,"lead_sponsor_name":"Momentum Data","has_results":true},{"nct_id":"NCT01947985","title":"Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)","phase":"","overall_status":"COMPLETED","enrollment_count":208958,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT02468102","title":"Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden)","phase":"","overall_status":"COMPLETED","enrollment_count":99999,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT01947998","title":"Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)","phase":"","overall_status":"COMPLETED","enrollment_count":50299,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT04574895","title":"Using a Real-Time Risk Prediction Model to Predict Pediatric Venous Thromboembolism (VTE) Events","phase":"NA","overall_status":"COMPLETED","enrollment_count":17427,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":false},{"nct_id":"NCT02943343","title":"The China Pulmonary Thromboembolism Registry Study","phase":"","overall_status":"UNKNOWN","enrollment_count":15000,"lead_sponsor_name":"China-Japan Friendship Hospital","has_results":false},{"nct_id":"NCT04535128","title":"COVID-19 Registry to Assess Frequency, Risk Factors, Management, and Outcomes of Arterial and Venous Thromboembolic Complications","phase":"","overall_status":"COMPLETED","enrollment_count":11000,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT02155491","title":"Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events","phase":"","overall_status":"COMPLETED","enrollment_count":10679,"lead_sponsor_name":"Thrombosis Research Institute","has_results":false},{"nct_id":"NCT02600260","title":"Thromboprophylaxis in Pregnant Women in Hospital: A Prospective Clinical Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":7212,"lead_sponsor_name":"University of Sao Paulo General Hospital","has_results":false},{"nct_id":"NCT03881345","title":"Ongoing Registry of Treatment of Venous Thromboembolism","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Medalp Private Surgery Clinic","has_results":false},{"nct_id":"NCT03129555","title":"The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE)","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Herlev and Gentofte Hospital","has_results":false},{"nct_id":"NCT02064439","title":"Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3365,"lead_sponsor_name":"Bayer","has_results":true},{"nct_id":"NCT06727669","title":"Longitudinal Cohort of Thrombosis and Hemostasis Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT06258694","title":"Venous Thrombo-Embolism Imaging Database (VTE-ID)","phase":"","overall_status":"COMPLETED","enrollment_count":2208,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT04436978","title":"What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"St. Antonius Hospital","has_results":false},{"nct_id":"NCT02210819","title":"Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy","phase":"","overall_status":"COMPLETED","enrollment_count":1987,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT06284343","title":"The Gynecological Cancer Associated Thrombosis (GynCAT) Study","phase":"","overall_status":"RECRUITING","enrollment_count":1800,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT06195540","title":"RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":1424,"lead_sponsor_name":"University Hospital, Angers","has_results":false},{"nct_id":"NCT04439383","title":"Risk Stratification for Venous Thromboembolism in Hospitalized Medical Patients","phase":"","overall_status":"COMPLETED","enrollment_count":1353,"lead_sponsor_name":"Insel Gruppe AG, University Hospital Bern","has_results":false},{"nct_id":"NCT05476913","title":"GEKO Venous Thromboembolism Prevention Study","phase":"NA","overall_status":"RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Firstkind Ltd","has_results":false},{"nct_id":"NCT05171049","title":"A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":1150,"lead_sponsor_name":"Anthos Therapeutics, Inc.","has_results":false},{"nct_id":"NCT01828697","title":"Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":1110,"lead_sponsor_name":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","has_results":false},{"nct_id":"NCT02073682","title":"Cancer Venous Thromboembolism (VTE)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1046,"lead_sponsor_name":"Daiichi Sankyo","has_results":true},{"nct_id":"NCT04719182","title":"Practice of Adjunctive Treatments in Intensive Care Unit Patients With COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":1011,"lead_sponsor_name":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","has_results":false},{"nct_id":"NCT03889457","title":"What Treatment for Patients With Phlebitis or Pulmonary Embolism ?","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Rennes University Hospital","has_results":false},{"nct_id":"NCT04373707","title":"Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Central Hospital, Nancy, France","has_results":false},{"nct_id":"NCT07432529","title":"Design and Rationale of the COLT Study","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":940,"lead_sponsor_name":"Azienda Sanitaria Locale ASL 6, Livorno","has_results":false},{"nct_id":"NCT07439991","title":"Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery","phase":"","overall_status":"RECRUITING","enrollment_count":900,"lead_sponsor_name":"The First Hospital of Jilin University","has_results":false},{"nct_id":"NCT04437303","title":"Periprocedural Continuation Versus Interruption of Oral Anticoagulant Drugs During Transcatheter Aortic Valve Implantation (POPular PAUSE TAVI)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":858,"lead_sponsor_name":"St. Antonius Hospital","has_results":false},{"nct_id":"NCT02744092","title":"Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":811,"lead_sponsor_name":"Alliance Foundation Trials, LLC.","has_results":true},{"nct_id":"NCT02297373","title":"Clinical Predictors for Venous Thromboembolism in Patients With a History of Thrombosis (PREDICTORS)","phase":"","overall_status":"COMPLETED","enrollment_count":744,"lead_sponsor_name":"Ottawa Hospital Research Institute","has_results":true},{"nct_id":"NCT04393909","title":"Improving Safety of Diagnosis and Therapy in the Inpatient Setting","phase":"NA","overall_status":"COMPLETED","enrollment_count":700,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT03937583","title":"Screening for Cancer in Patients With Unprovoked VTE","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":650,"lead_sponsor_name":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","has_results":false},{"nct_id":"NCT04168203","title":"Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":600,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":true},{"nct_id":"NCT03714048","title":"Blood Management During ECMO for Cardiac Support","phase":"","overall_status":"COMPLETED","enrollment_count":561,"lead_sponsor_name":"St Vincent's Hospital, Sydney","has_results":false},{"nct_id":"NCT02742623","title":"A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":528,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT04865913","title":"Venous Thrombosis Virtual Surveillance in COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":510,"lead_sponsor_name":"Ottawa Hospital Research Institute","has_results":false},{"nct_id":"NCT03006562","title":"PREvention of VENous ThromboEmbolism Following Radical Prostatectomy","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":501,"lead_sponsor_name":"Johns Hopkins University","has_results":true},{"nct_id":"NCT05464901","title":"VTE and the Related Factors Associated With Higher Rates of PE After a DVT in Southwestern China","phase":"","overall_status":"COMPLETED","enrollment_count":500,"lead_sponsor_name":"Wei Huang","has_results":false},{"nct_id":"NCT03909399","title":"Prevention and Prophylaxis of Cancer Associated Thrombosis in High Risk Oncology Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Hellenic Society of Medical Oncology","has_results":false},{"nct_id":"NCT04796740","title":"Thrombembolism After Robot- Assisted Surgery in Urology","phase":"","overall_status":"UNKNOWN","enrollment_count":450,"lead_sponsor_name":"University Hospital Schleswig-Holstein","has_results":false},{"nct_id":"NCT05195242","title":"The Effect of Dexamethasone 12 mg vs 6 mg on Thromboembolic Events in Patients With Critical COVID-19","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":445,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT03682419","title":"Evaluation of Precision and Accuracy of INR Measurements in a Point of Care Device (OPTIMAL)","phase":"NA","overall_status":"COMPLETED","enrollment_count":420,"lead_sponsor_name":"LumiraDx UK Limited","has_results":false},{"nct_id":"NCT05171075","title":"A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":417,"lead_sponsor_name":"Anthos Therapeutics, Inc.","has_results":false},{"nct_id":"NCT04272723","title":"Management of Venous Thromboembolism in France: a National Survey Among Vascular Medicine Physicians","phase":"","overall_status":"COMPLETED","enrollment_count":383,"lead_sponsor_name":"Centre Hospitalier Universitaire, Amiens","has_results":false},{"nct_id":"NCT03080883","title":"Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":370,"lead_sponsor_name":"Academic and Community Cancer Research United","has_results":true},{"nct_id":"NCT05449808","title":"Evaluation of Thromboprophylaxis Appropriateness in Hospitalized Medical Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":320,"lead_sponsor_name":"Al-Esraa University College","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}